Skip to content
BIA Survey “Understanding Key Elements of the Global Supply Chain"
Section 1: Background Information
1.
Are your company headquarters in the UK?
Yes
No
2.
Number of employees:
1-25
26-100
101-250
251-500
501-1000
>1000
3.
Number of approved products:
0
1-3
4-8
9-12
13-25
26-50
51-100
>100
4.
Number of your projects (or programs) in the clinical pipeline:
0
1-3
4-8
9-12
13-25
26-50
51-100
>100
5.
Your products in the pipeline or on the market are solely or primarily:
To treat rare diseases
To treat prevalent or highly prevalent diseases
Mix of both
Other (please specify)
6.
Your products in the pipeline or on the market are solely or primarily:
Small molecule
Biologic
Mix of both
Other (please specify)
7.
What are some of the primary diseases your clinical and/or marketed products treat?
Please list key diseases here:
